Switzerland Health Recent News, Events and Opinion on Allvoices
Front Page

Just In Switzerland Health News

 
 
 
Source: Inc.

Zurich :: Switzerland | updated 2014-07-25 10:58:13 -0700 | health-news

The Food and Drug Administration is reviewing research data on what could become the first U.S.-approved "biosimilar" drug, a cheaper, sort-of generic version of a biologic drug. Nearly five years after Congress passed a law enabling future approval of biosimilars,...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Source: PR Newswire

Lugano :: Switzerland | updated 2014-07-25 04:20:18 -0700 | health-news

EU General Data Protection Regulation includes a 'one-time consent' for research, ensuring patients are aware of what they are consenting to and can withdraw their consent at any time. "Our proposal actually 'empowers' patients, allowing them to donate their data...
Credibility  
Views: 1   News Stories: 0
Blog Posts: 0 0 0 0
 
 
 
Source: BusinessInsider

Zurich :: Switzerland | updated 2014-07-24 16:49:51 -0700 | health-news

Everyone who has a brain seems to like talking about brains, but there's a lot of misinformation floating around. Science video , Mitchell Moffit and Gregory Brown list seven of the most common brain myths and then explain why they...
Credibility  
Views: 1   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Source: The News Tribune

Zurich :: Switzerland | updated 2014-07-24 12:59:17 -0700 | health-news

The Food and Drug Administration is reviewing research data on what could become the first U.S.-approved "biosimilar" drug, a cheaper, sort-of generic version of a biologic drug. Five years after Congress passed a law allowing biosimilars, for the first time...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Source: Fox News

Zurich :: Switzerland | updated 2014-07-24 08:31:34 -0700 | health-news

Although little is currently known about the science of love at first sight or how people fall in love, these patterns of response provide the first clues regarding how automatic attentional processes, such as eye gaze, may differentiate feelings of...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Source: Pharmaceutical Industry News

Zurich :: Switzerland | updated 2014-07-22 09:03:51 -0700 | health-news

with Teva Pharmaceutical Industries' Israeli subsidiary, Abic Marketing Limited. Israel for weight loss or weight management in obese and overweight patients, subject to regulatory approval by the State of Israel Ministry of Health (MOH). Israel as a new treatment option...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Breaking News: Michael Schumacher now communicating with family by fluttering eyelashes
 
Source: Daily News & Analysis

Zurich :: Switzerland | updated 2014-07-22 08:37:33 -0700 | health-news

A report has revealed that he is now communicating with his family members by fluttering his eyelashes. The recovery shown by Schumacher may allow him to go back home soon but he will still require round-the-clock medical care to recover completely,...
Credibility  
Views: 1   News Stories: 2
Blog Posts: 0 0 1 0
 
 
Source: Medgadget.com

Zurich :: Switzerland | updated 2014-07-21 13:10:13 -0700 | health-news

The Zone C410 has the step tracking functionality of all the other wearables, but as Salutron has its roots as a pioneer in on-demand ECG heart rate monitoring, it prides itself in having advanced heart rate monitoring technology. We've spent the last couple months with the...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Source: Mail Online UK

Lausanne :: Switzerland | updated 2014-07-21 07:06:36 -0700 | health-news

Michael Schumacher 'could be home from hospital by the end of the summer' as reports say neurosurgeons have been approached to plant microchip in his brain Swiss media report the Formula 1 legend 'will leave the clinic soon and could...
Credibility  
Views: 2   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Source: The Motley Fool

Zurich :: Switzerland | updated 2014-07-20 15:30:27 -0700 | health-news

With the clinical trial failure rate for Alzheimer's drugs an astounding 99.6%,  major drugmakers have seen one promising Alzheimer's treatment after another fail. The list include Bapineuzumab ( Pfizer / Johnson & Johnson ), Flurizan ( Myriad Genetics ), and...
Credibility  
Views: 1   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Source: The Hindu

Zurich :: Switzerland | updated 2014-07-19 03:29:24 -0700 | health-news

Get your vitamins Vitamin B-7 is essential for converting food into energy, and it plays a role in keeping your skin, nerves and digestive tract healthy...You can get your daily supply from HA-omega-3-rich salmon; avocados; nuts; dark chocolate; and 100...
Credibility  
Views: 2   News Stories: 0
Blog Posts: 0 0 0 0
 
 
 
Source: Reuters

Basel :: Switzerland | updated 2014-07-19 00:52:41 -0700 | health-news

Swiss pharmaceutical company Roche CEO Severin Schwan talks to media during the annual results media conference at their headquarters in Basel January 30, 2014. Roche plans to steer clear of the wave of big takeovers sweeping through the healthcare industry...
Credibility  
Views: 1   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Source: The Guardian

Zurich :: Switzerland | updated 2014-07-17 10:30:25 -0700 | health-news

Guardian staff Files at the Dignitas offices in Zurich, Switzerland. Photograph: David Levene for the Guardian In April 2002, the Netherlands became the first country to legalise euthanasia and assisted suicide. It imposed a strict set of conditions: the patient...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Source: Pharmaceutical Industry News

Zurich :: Switzerland | updated 2014-07-17 08:58:40 -0700 | health-news

Imugene' cancer immunotherapy vaccine candidate HER-Vaxx is scheduled to enter into a Phase I/II clinical trial in 2015. Under the deal, Mymetics will use its strong experience and specialist know-how in virosome based vaccines and integrating antigens in viral membranes...
Credibility  
Views: 5   News Stories: 0
Blog Posts: 0 0 0 0
 
Breaking News: Novartis posts 3 percent profit rise for 2Q, cites strong momentum for new product development
 
Source: Star Tribune

Geneva :: Switzerland | updated 2014-07-17 04:08:49 -0700 | health-news

Swiss pharmaceutical company Novartis AG posted a 3 percent rise in second-quarter profits Thursday, reflecting what it described as solid growth and an increased focus on core products. Profits during the April-June quarter rose to $3.28 billion, up from $3.18...
Credibility  
Views: 0   News Stories: 2
Blog Posts: 0 0 5 0
 

Contributors

Build Your Allvoices Brand. Gain Influence. Make Money.

Join the Build Your Allvoices Brand Incentive Program



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.